/Investor DB

Boomerang Ventures — 2025 Investments

3 investments dated 2025 · listed companies and verified rows first · show all

SynchNeurosynchneuro.comNov 2025✓ verified

SynchNeuro develops a non-invasive, behind-the-ear wearable sensor that analyzes brain signals (EEG) to continuously monitor glucose levels, sleep quality, and other metabolic metrics.

AI & Machine LearningDigital HealthMedical Devices

Casey Halpern(Founder & Chairman)Emily Mirro(Co-Founder & President)inHeonsoo Lee(Chief Scientist)in

Sitelabsglobalsitelabsglobal.comNov 2025 · $2M

SiteLabs works with independent pharmacies in the U.S. to offer preventive health screenings, close gaps in care, and recruit patients for clinical trials, using pharmacies as neighborhood screening and recruitment hubs.

BiotechDigital HealthHealthtechSeneca, US

Darren Schaupp(Executive Officer, Director)inEric Beier(Director)in

BoardJames Bauler(Director)Stephen Fischbach(Director)Warren Dodge(Director)

Sonara Healthsonarahealth.comin𝕏Sep 2025

Sonara provides a hybrid care model for opioid treatment programs that combines at-home medication management with remote monitoring and clinical oversight.

Digital HealthHealthtechMedical DevicesDallas, US

Michael Giles(Chief Executive Officer)inJUSTIN GELLER(Executive Officer)in

BoardRACHEL KERN(Director)inDANIEL R. KARLIN(Director)

Co-investorsAcumen AmericaRoyal Street Ventures Management Company, LlcFirst Trust Capital PartnersSorenson Impact Foundation

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.